Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
All patients undergoing intestinal resection surgery
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 30 days post operatively
Awards & highlights
Study Summary
This trial is comparing the use of small doses of ICG (a fluorescent dye) to the usual standard doses of ICG for assessing blood flow during surgery.
Who is the study for?
This trial is for patients who are scheduled to have intestinal resection surgery. It's not suitable for pregnant individuals or those with kidney problems.Check my eligibility
What is being tested?
The study is testing the use of tiny doses of a dye called ICG compared to regular doses, to see how well blood flows through the colon during surgery.See study design
What are the potential side effects?
ICG may cause allergic reactions, including anaphylaxis. Other side effects can include nausea, vomiting, and skin rashes.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am scheduled for or have had surgery to remove part of my intestines.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 30 days post operatively
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 30 days post operatively
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
ability to assess perfusion
Trial Design
2Treatment groups
Active Control
Group I: regular dose ICGActive Control1 Intervention
Group II: micro dose icgActive Control1 Intervention
Find a Location
Who is running the clinical trial?
Shanglei LiuLead Sponsor
Share this study with friends
Copy Link
Messenger